SASAKI HIROSHI 佐々木浩

… Alternative Names

Researcher Number	80432491
Affiliation (Current)	2020: 大阪医科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help	2015 – 2019: 大阪医科大学, 医学部, 講師 2017: 大阪医科大学, 医学部, 助教 2014: 大阪医科大学, 医学部, 助教 2007 – 2012: 大阪医科大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Obstetrics and gynecology Except Principal Investigator Obstetrics and gynecology / Basic Section 56040:Obstetrics and gynecology-related
Keywords	Principal Investigator 卵巣癌 / シスプラチン / トポテカン / プラチナ耐性 / Akt / NF・B / VEGF / NFκB / NFкB / エキソソーム … More Except Principal Investigator 卵巣癌 / EMT / CD24 / GPR30 / 子宮内膜癌 / 上皮間葉形質転換 / E-cadherin / 癌幹細胞 / 癌 / snail / 抗癌剤耐性 / EGFR / 白金製剤耐性卵巣癌 / 浸潤・転移 / 婦人科癌 / EMT現象 / 婦人科悪性腫瘍 / 高分子ミセル / miRNA / 子宮頚癌 / マイクロアレイ / 薬剤反応性 / シグナル伝達 / トランスレーショナルリサーチ / シスプラチン / タキソール / アポトーシス / プロモーターマイクロアレイ / NFkB / SiRNA / IAPファミリー / アデノウイルス / 耐性卵巣癌 / 分子標的治療 / イレッサ / 婦人科腫瘍学 / 抗血管新生治療 / 維持療法 / slug / プロゲステロン受容体 / 上皮性卵巣癌 / Akt-mTOR-HIF / VEGF / 幹細胞 / 薬剤耐性 / Snail / E-chadherin / Epithelial Mesenchymal Transition / E-cadherino / Slug / CD24, 婦人科悪性腫瘍 / EMT, 高分子ミセル / ミセル / 卵巣毒性 / アルキル化剤 / 顆粒膜細胞 / テストステロン / AMH / 卵巣保護 / 抗がん剤 / mi RNA / エキソソーム / 癌関連繊維芽細胞 / 子宮体がん / 肥満 / 癌関連線維芽細胞 / 子宮体癌 / exosome / マイクロRNA / エクソソーム / lipid raft / 化学療法抵抗性 / MET / ＣＤ２４ / ＥＭＴ / ＧＰＩアンカー型タンパク質 / ラフト形成 / ＧＰＩアンカー型蛋白質 / ドラッグデリバリーシステム / 上皮・間葉形態転換 / ニッチ / 上皮間葉形態転換 / Endothelinー2 / BNCT / 硼素化合物 / 硼素内包高分子ミセル / 癌免疫治療 / 細胞外小胞 / 臨床腫瘍直接移植モデル / エリブリン / 免疫応答 / T細胞 / 難治性卵巣癌 / 腫瘍免疫 Less

複合的癌免疫治療による子宮頚癌治療の革新的開発Ongoing
- Principal Investigator
  
  林正美
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical College
Analysis of extracellular vesicles using patient derived xenograftOngoing
- Principal Investigator
  
  田中智人
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical College
エリブリンによる腫瘍免疫を介した難治性卵巣癌に対する新たな治療戦略Ongoing
- Principal Investigator
  
  藤原聡枝
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical College
Research for cancer microenvironment via FABP4 in endometrial cnacerPrincipal InvestigatorOngoing
- Principal Investigator
  
  佐々木浩
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
EMTとニッチの制御を目指した高分子ミセルを用いた難治性卵巣癌に対する治療の開発Ongoing
- Principal Investigator
  
  大道正英
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
子宮頸癌におけるCD24高分子ミセルを利用した硼素中性子補足療法の治療戦略Ongoing
- Principal Investigator
  
  恒遠啓示
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
A novel miRNA regulates the EMT and MMT of peritoneal mesothelium in ovarian cancer
- Principal Investigator
  
  Terai Yoshito
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Kobe University
  Osaka Medical College
activation regulatory mechanism of cancer fibroblast by obesity
- Principal Investigator
  
  Takai Masaaki
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
A novel approach for cervical cancer using exosome
- Principal Investigator
  
  Hayashi Masami
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Analysis of lipid raft via CD24 and drug resistance in gynecologic cancer
- Principal Investigator
  
  Tanaka Yoshimichi
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Testosterone for the Prevention of Cyclophosphamide -Induced Ovarian Toxicity
- Principal Investigator
  
  Tanabe Akiko
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
GPR30 signaling regulates Epithelial-Mesenchymal Transition in ovarian cancer
- Principal Investigator
  
  Fujiwara Satoe
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
The elucidation of the mechanism in cancer microenvironment by ovarian cancer secretion exosome and the development of a next-generation cancer therapy by the exosome.Principal Investigator
- Principal Investigator
  
  SASAKI HIROSHI
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
EMT including cancer stem cells regulates invasion and metastasis of uterine endometrial cancer.
- Principal Investigator
  
  TERAI Yoshito
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Developing of polymeric micelle for molecular targeting to cancer stem cells in ovarian cancer patients.
- Principal Investigator
  
  OHMICHI Masahide
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Analysis of the role of MPA as a molecular-targeted therapy in endometrial cancer.
- Principal Investigator
  
  KANEMURA Masanori
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Basic research of cancer stem cell for therapeutic target in cisplatin-resistant ovarian cancer.
- Principal Investigator
  
  TANABE Akiko
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Analysis of a new molecule target action of topotecan using a promoter microarrayPrincipal Investigator
- Principal Investigator
  
  SASAKI Hiroshi
- Project Period (FY)
  2009 – 2010
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Basic research of either bevacizumab or gefitinib in platinum-resistant ovarian cancer.
- Principal Investigator
  
  TERAI Yoshito
- Project Period (FY)
  2007 – 2009
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Analysis of chemo-resistance genes with promoter micro-array in ovarian cancer
- Principal Investigator
  
  OHMICHI Masahide
- Project Period (FY)
  2006 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College

All 2018 2017 2014 2012 2011 2010 2009 2008 Other

All Journal Article Presentation

[Journal Article] A case of ovarian clear cell carcinoma arising from ovarian mature cystic teratoma2018
- Author(s)
  Maeda Kazuya、Terai Yoshito、Terada Shinichi、Maruoka Hiroshi、Kogata Yuhei、Ashihara Keisuke、Tanaka Yoshimichi、Tanaka Tomohito、Sasaki Hiroshi、Tsunetoh Satoshi、Yamada Takashi、Ohmichi Masahide
- Journal Title
  
  Journal of Ovarian Research
  
  Volume: 11 Pages: 74-74
- DOI
  10.1186/s13048-018-0446-4
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K11165
[Journal Article] The efficacy of the cyclin-dependent kinase 4/6 inhibitor in endometrial cancer.2017
- Author(s)
  anaka T, Terai Y, Ashihara K, Fujiwara S, Tanaka Y, Sasaki H, Tsunetoh S, Ohmichi M
- Journal Title
  
  PLoS One
  
  Volume: 12
- DOI
  10.1371/journal.pone.0177019
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26462541
[Journal Article] CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways2017
- Author(s)
  Nakamura K, Terai Y, Tanabe A, Ono YJ, Hayashi M, Maeda K, Fujiwara S, Ashihara K, Nakamura M, Tanaka Y, Tanaka T, Tsunetoh S, Sasaki H, Ohmichi M.
- Journal Title
  
  Oncology Reports
  
  Volume: - Pages: 3189-3200
- DOI
  10.3892/or.2017.5583
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26462541, KAKENHI-PROJECT-16K11162, KAKENHI-PROJECT-16K11165, KAKENHI-PROJECT-17K11304
[Journal Article] The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer.2014
- Author(s)
  Takai M, Terai Y, Kawaguchi H, Ashihara K, Fujiwara S, Tanaka T, Tsunetoh S, Tanaka Y, Sasaki H, Kanemura M, Tanabe A, Ohmichi M.
- Journal Title
  
  J Ovarian Res
  
  Volume: 76 Pages: 1-5
- DOI
  10.1186/1757-2215-7-76
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24592536, KAKENHI-PROJECT-25670709, KAKENHI-PROJECT-26462541
[Journal Article] Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer.2014
- Author(s)
  Kawaguchi H, Terai Y, Tanabe A, Sasaki H, Takai M, Fujiwara S, Ashihara K, Tanaka Y, Tanaka T, Tsunetoh S, Kanemura M, Ohmichi M.
- Journal Title
  
  J Ovarian Res
  
  Volume: 7 Pages: 38-38
- DOI
  10.1186/1757-2215-7-38
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25670709, KAKENHI-PROJECT-26462541
[Journal Article] GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer.2012
- Author(s)
  Fujiwara S, Terai Y(分担)、Kawaguchi H, Takai M, Yoo S, Tanaka Y, Tanaka T,Tsunetoh S, Sasaki H (分担)、Kanemura M (分担)、Tanabe A (分担)、Ohmichi M (代表)
- Journal Title
  
  Journal of Ovarian Research
  
  Volume: 5(1) Pages: 35-44
- Data Source
  KAKENHI-PROJECT-22659303
[Journal Article] Prognostic effect of epidermal growth factor receptor gene mutations and the aberrant phosphorylation of Akt and ERK in ovarian cancer.2011
- Author(s)
  Tanaka Y, Sasaki H, Ohmichi M.
- Journal Title
  
  Cancer Biol Ther. 11(1)
  
  Pages: 50-57
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21791578
[Journal Article] Prognostic effect of epidermal growth factor receptor gene mutations and the aberrant phosphorylation of Akt and ERK in ovarian cancer.2011
- Author(s)
  Tanaka Y, Terai Y*, Tanabe A, Sasaki H, Sekijima T, Fujiwara S, Yamashita Y, Kanemura M, Ueda M, Sugita M, Franklin WA, Ohmichi M.
- Journal Title
  
  Cancer Biol Ther
  
  Volume: 11 Pages: 50-57
- Data Source
  KAKENHI-PROJECT-22591869
[Journal Article] Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cances.2010
- Author(s)
  佐々木浩, 恒遠啓示
- Journal Title
  
  Cancer Biology and Therapy.
  
  Volume: 11 Pages: 1137-1137
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21791578
[Journal Article] Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancers.2010
- Author(s)
  Tsunetoh S, Sasaki H, Ohmichi M.
- Journal Title
  
  Cancer Biol Ther. 10(11)
  
  Pages: 1137-1146
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21791578
[Journal Article] Long-term follow-up of neoadjuvant intraarterial chemotherapu using an original four-lumen double balloon(4L-DB) catheter for locally advanced uterine cervical cancer.2009
- Author(s)
  Terai Y, Kanemura M, Sasaki H, Tsunetoh S, Tanaka Y, Yamashita Y, Yamamoto K, Narabayashi I, Ohmichi M.
- Journal Title
  
  Int J Clin Oncol 14
  
  Pages: 56-62
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591946
[Journal Article] Maintenance treatment with bevacizumab prolong survival in an in vivo ovarian cancer model.2008
- Author(s)
  Mabuchi S, Terai Y, Morishige K, Kimura-Tanabe A, Sasaki H, Kanemura M, Tsunetoh S, Tanaka Y, Sakata Y, Burger R, Kimura T, Ohmichi M.
- Journal Title
  
  Clin Cancer Res 14(23)
  
  Pages: 7781-7789
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591946
[Journal Article] Defference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines2008
- Author(s)
  佐々木浩
- Journal Title
  
  Oncogene 27
  
  Pages: 2737-2745
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591946
[Presentation] 子宮内膜症合併卵巣がんと脂質異常症は関連しているか？2018
- Author(s)
  佐々木浩
- Organizer
  第70回日本産科婦人科学会
- Data Source
  KAKENHI-PROJECT-17K11303
[Presentation] GPR30 signaling regulates Epithelial-Mesenchymal Transition in ovarian cancer2018
- Author(s)
  藤原聡枝　田中良道　田中智人　恒遠啓示　佐々木浩　寺井義人　大道正英
- Organizer
  International Gynecologic Cancer Society 2018
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K10738
[Presentation] 内臓脂肪と子宮体癌の臨床病理学的特徴の関係2018
- Author(s)
  丸岡寛、佐々木浩
- Organizer
  第33回日本女性医学学会学術集会
- Data Source
  KAKENHI-PROJECT-17K11303
[Presentation] 子宮内膜症合併卵巣がんと脂質異常症は関連しているか？2018
- Author(s)
  佐々木浩
- Organizer
  第70回日本産科婦人科学会
- Data Source
  KAKENHI-PROJECT-16K11163
[Presentation] 難治性卵巣癌モデルマウスに対するCD24を標的とした高分子ミセルを用いた新規治療2017
- Author(s)
  芦原敬允, 寺井義人, 土橋裕允, 藤原聡枝, 田中良道, 田中智人, 恒遠啓示, 佐々木浩, 林正美, 大道正英
- Organizer
  第69回日本産科婦人科学会学術集会
- Data Source
  KAKENHI-PROJECT-17K11304
[Presentation] 生活習慣病からみた子宮体がんの臨床病理学的特徴2017
- Author(s)
  佐々木浩
- Organizer
  第69回日本産科婦人科学会学術講演会
- Data Source
  KAKENHI-PROJECT-16K11163
[Presentation] MicroRNA-22を介した子宮頸癌の分子標的治療への応用2017
- Author(s)
  中村真由美、林正美、橋田宗祐、丸岡寛、小西博巳、前田和也、田中良道、佐々木浩、寺井義人、大道正英
- Organizer
  日本産婦人科学会学術講演会
- Data Source
  KAKENHI-PROJECT-16K11164
[Presentation] 生活習慣病からみた子宮体がんの臨床病理学的特徴2017
- Author(s)
  佐々木浩
- Organizer
  第69回日本産科婦人科学会学術講演会
- Data Source
  KAKENHI-PROJECT-17K11303
[Presentation] 子宮体癌における EMT のマーカーとしての CD24 の有用性2012
- Author(s)
  田中良道、寺井義人、斎藤奈津穂、川口浩史、中村路彦、兪史夏、藤原聡枝、佐々木浩、恒遠啓示、金村昌徳、田辺晃子、大道正英
- Organizer
  第64回日本産科婦人科学会
- Place of Presentation
  神戸
- Data Source
  KAKENHI-PROJECT-22591869
[Presentation] エストロゲン受容体GPR30の子宮内膜癌における制御機構の解明2011
- Author(s)
  佐々木浩、金村昌徳大道正英
- Organizer
  第63回日本産婦人科学会学術講演会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-21592148
[Presentation] 卵巣癌におけるGPR30の免疫組織化学的検討2010
- Author(s)
  佐々木浩
- Organizer
  癌治療学会
- Place of Presentation
  国立京都国際会館
- Year and Date
  2010-10-28
- Data Source
  KAKENHI-PROJECT-21791578
[Presentation] 子宮内膜癌に対するmedroxyprogesterone acetate(MPA)の作用機序2010
- Author(s)
  佐々木浩
- Organizer
  第61回日本産科婦人科学会総会・学術講演会
- Data Source
  KAKENHI-PROJECT-21791578
[Presentation] 卵巣癌における抗癌剤感受性に基づいた新規 molecular marker としてのNFκB の意義2010
- Author(s)
  佐々木浩
- Organizer
  第62回日本産科婦人科学会総会・学術講演会
- Data Source
  KAKENHI-PROJECT-21791578
[Presentation] Topoisomerase linhibitor であるtopotecan のCDDP 耐性解除機構2009
- Author(s)
  佐々木浩
- Organizer
  第60回日本産科婦人科学会総会・学術講演会
- Data Source
  KAKENHI-PROJECT-21791578
[Presentation] 子宮内膜癌に対する medroxyprogesterone acetate(MPA)の作用機序2009
- Author(s)
  佐々木浩
- Organizer
  第61回日本産科婦人科学会学術講演会
- Place of Presentation
  国立京都国際会館
- Year and Date
  2009-04-03
- Data Source
  KAKENHI-PROJECT-21791578
[Presentation] 当科における難治性卵巣癌(明細胞腺癌、粘液性腺癌)の治療成績2009
- Author(s)
  佐々木浩
- Organizer
  第47回日本癌治療学会学術集会
- Place of Presentation
  パシフィコ横浜
- Year and Date
  2009-10-22
- Data Source
  KAKENHI-PROJECT-19591946
[Presentation] 子宮内膜癌に対するMPAの作用機序2009
- Author(s)
  佐々木浩, 金村昌徳
- Organizer
  第61回日本産科婦人科学会総会学術講演会
- Place of Presentation
  京都
- Year and Date
  2009-04-05
- Data Source
  KAKENHI-PROJECT-21592148
[Presentation] topoisomerase I inhibitorであるtopotecanはin vivoにおいてcddp耐性を解除するか?2008
- Author(s)
  恒遠啓示, 寺井義人, 金村昌徳, 竹原幹雄, 佐々木浩, 田中良道, 田辺晃子, 大道正英
- Organizer
  第60回日本産科婦人科学会総会・学術講演会
- Place of Presentation
  パシフィコ横浜
- Data Source
  KAKENHI-PROJECT-19591946
[Presentation] topoisomerase I inhibitor であるtopotecan はin vivo においてCDDP耐性を解除するか?2008
- Author(s)
  恒遠啓示、佐々木浩
- Organizer
  第60回日本産科婦人科学会総会・学術講演会
- Data Source
  KAKENHI-PROJECT-21791578
[Presentation] Topoisomerase 1 inhibitorであるtopotecanのCDDP耐性解除機構2008
- Author(s)
  佐々木浩, 寺井義人, 金村昌徳, 竹原幹雄, 恒遠啓示, 田中良道, 田辺晃子, 大道正英
- Organizer
  第60回日本産科婦人科学会総会・学術講演会
- Place of Presentation
  パシフィコ横浜
- Data Source
  KAKENHI-PROJECT-19591946
[Presentation] Topoisomerase 1 inhibitorであるtopotecanのin vivoにおけるCDDP耐性を解除の解明2008
- Author(s)
  恒遠啓示, 寺井義人, 川辺紗智子, 加藤壮介, 藤岡聡枝, 田中良道, 佐々木浩, 金村昌徳, 田辺晃子, 大道正英
- Organizer
  第46回日本癌治療学会総会
- Place of Presentation
  名古屋国際会議場
- Data Source
  KAKENHI-PROJECT-19591946
[Presentation] 当科における白金製剤耐性卵巣癌におけるGemcitabine単剤療法の有効性2008
- Author(s)
  佐々木浩, 加藤壮介, 川辺紗智子, 藤岡聡枝, 田中良道, 恒遠啓示, 金村昌徳, 田辺晃子, 寺井義人, 大道正英
- Organizer
  第46回日本癌治療学会総会
- Place of Presentation
  名古屋国際会議場
- Data Source
  KAKENHI-PROJECT-19591946
[Presentation] 卵巣癌におけるEGFR遺伝子のmutation、発現とAKT、ERKの活性化の臨床的意義」2008
- Author(s)
  田中良道, 寺井義人, 加藤壮介, 川辺紗智子, 藤岡聡枝, 佐々木浩, 恒遠啓示, 金村昌徳, 田辺晃子, 大道正英
- Organizer
  第46回日本癌治療学会総会
- Place of Presentation
  名古屋国際会議場
- Data Source
  KAKENHI-PROJECT-19591946
[Presentation] 卵巣癌におけるEGFR 遺伝子変異とその下流シグナル分子の発現解析
- Author(s)
  田中良道、佐々木浩、大道正英
- Data Source
  KAKENHI-PROJECT-21791578

1. OHMICHI Masahide (10283764)

# of Collaborated Projects: 19 results

# of Collaborated Products: 19 results
2. TERAI Yoshito (90278531)

# of Collaborated Projects: 19 results

# of Collaborated Products: 18 results
3. TANABE Akiko (70454543)

# of Collaborated Projects: 15 results

# of Collaborated Products: 12 results
4. Tanaka Yoshimichi (10625502)

# of Collaborated Projects: 12 results

# of Collaborated Products: 8 results
5. Hayashi Masami (00551748)

# of Collaborated Projects: 12 results

# of Collaborated Products: 3 results
6. Fujiwara Satoe (90707960)

# of Collaborated Projects: 11 results

# of Collaborated Products: 4 results
7. 恒遠啓示 (70388255)

# of Collaborated Projects: 11 results

# of Collaborated Products: 7 results
8. KANEMURA Masanori (40298782)

# of Collaborated Projects: 9 results

# of Collaborated Products: 14 results
9. 兪史夏 (80625674)

# of Collaborated Projects: 6 results

# of Collaborated Products: 0 results
10. 田中智人 (90411363)

# of Collaborated Projects: 6 results

# of Collaborated Products: 1 results
11. SAKATA Masahiro (10260639)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
12. TAKEHARA Mikio (40298766)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
13. 古形祐平 (80829953)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
14. YAMASHITA Yoshiki (50268207)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. KAMEGAI Hideki (30204639)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. TASAKA Keiichi (50155058)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
17. TAHARA Masahiro (00294091)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
18. HAYAKAWA Jun (80397736)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
19. HASHOMOTO Namiko (60379253)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
20. Takai Masaaki (90770933)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

SASAKI HIROSHI 佐々木 浩

SASAKI Hiroshi 佐々木 浩

Research Projects

Research Products

Co-Researchers

複合的癌免疫治療による子宮頚癌治療の革新的開発Ongoing

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Analysis of extracellular vesicles using patient derived xenograftOngoing

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

エリブリンによる腫瘍免疫を介した難治性卵巣癌に対する新たな治療戦略Ongoing

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Research for cancer microenvironment via FABP4 in endometrial cnacerPrincipal InvestigatorOngoing

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

EMTとニッチの制御を目指した高分子ミセルを用いた難治性卵巣癌に対する治療の開発Ongoing

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

子宮頸癌におけるCD24高分子ミセルを利用した硼素中性子補足療法の治療戦略Ongoing

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The elucidation of the mechanism in cancer microenvironment by ovarian cancer secretion exosome and the development of a next-generation cancer therapy by the exosome.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

SASAKI HIROSHI 佐々木浩

SASAKI Hiroshi 佐々木浩